Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05185687 · ClinicalTrials.gov registry record · NA
Public Support for COVID-19 Test Allocation
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 2,019
- Enrollment target
NCT05185687: Completed NA study, sponsored by University of Pennsylvania.
NCT05185687 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 2,019 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05185687, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,019 participants
- Enrollment target
Study Summary
In a randomized survey experiment, investigators will assess public support or opposition towards one of three potential government plans for allocating at-home coronavirus disease 2019 (COVID-19) tests to United States residents: 1) first come, first served; 2) a random draw; or 3) a random draw with 20% of tests reserved for disadvantaged areas. Investigators will also examine public attitudes surrounding other logistical and equity-related aspects of these allocation plans.
Primary Outcome
Self-reported degree of support for the plan, measured on a 5-point Likert scale ("strongly oppose" to "strongly support") that will be collapsed into 3 response categories ("oppose," "neutral," and "support") for analysis.
Interventions
- BEHAVIORAL First Come, First Served
- BEHAVIORAL Random
- BEHAVIORAL Disadvantaged Priority & Random
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,019 participants |
| Start Date | 2022-01-04 |
| Est. Completion | 2022-01-06 |
| Phase | NA |
What the finished NCT05185687 record still lists
NCT05185687 is an interventional study that assigns participants to a tested intervention. Its 2,019 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% higher).
The record links to 0 conditions, and to 3 interventions - of which First Come, First Served is the first listed.
NCT05185687 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05185687 about?
NCT05185687 is a clinical study titled "Public Support for COVID-19 Test Allocation". In a randomized survey experiment, investigators will assess public support or opposition towards one of three potential government plans for allocating at-home coronavirus disease 2019 (COVID-19) tests to United States residents: 1) first come, first served; 2) a random draw; or 3) a random draw wi...
What is the current status of trial NCT05185687?
This trial is currently completed. It is a NA study. The enrollment target is 2,019 participants. The study started on 2022-01-04. Estimated completion is 2022-01-06.
What interventions are being tested in trial NCT05185687?
The interventions under investigation include: First Come, First Served (BEHAVIORAL), Random (BEHAVIORAL), Disadvantaged Priority & Random (BEHAVIORAL).
Who is sponsoring clinical trial NCT05185687?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05185687's enrollment target sits among peer trials
2,019 52nd of 2000 higher than 1,949 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- NCT04100564 · 2,009 participants · NA
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
- NCT04216732 · 2,030 participants
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI